COVID-19 Antibodies & Supporting Reagents

Rockland has a long-established history of providing critical antibodies and reagents as a qualified raw material supplier—specifically in the area of infectious disease and in vitro diagnostics. Our antibodies specific to SARS-CoV-2 Nucleocapsid and Spike proteins are being used both directly and indirectly for vaccine development, drug discovery, diagnostics, and COVID-19 research by our global network of collaborators. Since the discovery of SARS-CoV-2, Rockland has been producing antibodies targeting various viral proteins, including the Membrane protein, 3CL Protease, and Non-Structural Protein 3 (NSP3) and 8 (NSP8).